Abstract
This chapter reviews the diagnosis and management of overactive bladder (OAB) and urinary incontinence (UI) in men. OAB is a syndrome characterized by urinary urgency, frequency, and nocturia. In some individuals with OAB, the urgency will result in urge UI. The other major type of incontinence is stress UI, caused by a loss of urethral sphincter function. Although these symptoms occur about half as often in men as in women, they are a source of considerable bother and frustration when they are present. A thorough history, physical examination, and urinalysis are sufficient to guide initial therapy. Men with complicated symptoms (concomitant pain or hematuria, recurrent infections, poor bladder emptying, severe symptoms, prior pelvic radiation, neurologic disease, or major pelvic surgery) should be referred for specialized management. Behavioral therapies such as dietary modification, bladder training, and pelvic muscle exercises may be beneficial for symptoms of OAB, urge UI, and stress UI. Antimuscarinic medications are commonly used to treat OAB and urge UI. For refractory symptoms, sacral nerve stimulation is an effective surgical option. Stress UI in men is typically caused by prior prostate surgery. The most common treatments for male stress UI are transurethral injections of bulking agents, placement of a perineal sling, and implantation of an artificial urinary sphincter. External (condom) catheters and penile clamps are useful adjunctive measures for UI, which may be applicable for certain men.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abrams P, Artibani W, Cardozo L, et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2006;25:293.
Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352–60.
Onukwugha E, Zuckerman I, McNally D, et al. The total economic burden of overactive bladder in the United States: a disease-specific approach. Am J Manag Care. 2009;15:S90–7.
Buckley BS, Lapitan MCM, Epidemiology Committee of the Fourth International Consultation on Incontinence, Paris, 2008. Prevalence of urinary incontinence in men, women, and children – current evidence: findings of the fourth International Consultation on Incontinence. Urology. 2010;76(2):265–70.
Stothers L, Thom DH, Calhoun EA. Urinary incontinence in men. In: Litwin MS, Saigal CS, editors. Urologic diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Publishing Office; 2007. Ch. 6, p. 193–222.
Shamliyan TA, Wyman JF, Ping R, et al. Male urinary incontinence: prevalence, risk factors, and preventive interventions. Rev Urol. 2009;11:145.
Thom D. Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type. J Am Geriatr Soc. 1998;46:473.
Tennstedt SL, Chiu GR, Link CL, et al. The effects of severity of urine leakage on quality of life in Hispanic, white and black men and women: the Boston Area Community Health survey. Urology. 2010;75:27.
Lagro-Janssen TALM, Hilkens CJM, Klaasen RI, et al. Greater emotional and social effect of urinary incontinence in men than women. J Am Geriatr Soc. 2008;56:1779.
Roosen A, Chapple C, Dmochowski R, et al. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009;56:810–20.
Andersson KE, Gratske C, Hedlund P. The role of the transient receptor potential (TRP) superfamily if the cation-selective channels in the management of overactive bladder. BJU Int. 2010;106(8):1114–27.
Rieken M, Mundorff NE, Bonkat G, et al. Complications of laser prostatectomy: a review of recent data. World J Urol. 2010;28:53.
Thiel DD, Petrou SP. Electroresection and open surgery. Urol Clin North Am. 2009;36:461.
Lerner LB, Tyson MD. Holmium laser applications of the prostate. Urol Clin North Am. 2009;36:485.
Loughlin KR, Prasad MM. Post-prostatectomy incontinence: a confluence of 3 factors. J Urol. 2010;183:871.
Hammerer P, Huland H. Urodynamic evaluation of changes in urinary control after radical prostatectomy. J Urol. 1997;157:233.
Donnellan SM, Duncan HJ, MacGregor RJ, et al. Prospective assessment of incontinence after radical retropubic prostatectomy: objective and subjective analysis. Urology. 1997;49:225.
Eastham JA, Kattan MW, Rogers E, et al. Risk factors for urinary incontinence after radical prostatectomy. J Urol. 1996;156:1707.
Litwin MS, Hayes RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129.
Penson DF, McLerran D, Feng Z, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol. 2005;173:1701.
Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346:1138.
Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790.
Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the prostate cancer outcomes study. JAMA. 2000;283:354.
Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29:213.
Burgio KL, Goode PS, Urban DA, et al. Preoperative biofeedback assisted behavioral training to decrease post-prostatectomy incontinence: a randomized, controlled trial. J Urol. 2006;175:196.
Filocamo MT, Li Marzi V, Del Popolo G, et al. Effectiveness of early pelvic floor rehabilitation treatment for post-prostatectomy incontinence. Eur Urol. 2005;48:734.
Van Kampen M, De Weerdt W, Van Poppel H, et al. Effect of pelvic floor re-education on duration and degree of incontinence after radical prostatectomy: a randomized controlled trial. Lancet. 2000;355:98.
Bales GT, Gerber GS, Minor TX, et al. Effect of preoperative biofeedback/pelvic floor training on continence in men undergoing radical prostatectomy. Urology. 2000;56:627.
Mathewson-Chapman M. Pelvic muscle exercise/biofeedback for urinary incontinence after prostatectomy: an education program. J Cancer Educ. 1997;12:218.
Franke JJ, Gilbert WB, Grier J, et al. Early post-prostatectomy pelvic floor biofeedback. J Urol. 2000;163:191.
Moore KN, Griffiths D, Houghton A. Urinary incontinence after radical prostatectomy: a randomized controlled trial comparing pelvic muscle exercises with or without electrical stimulation. BJU Int. 1999;83:57.
Hunter KF, Moore KN, Glazener CMA. Conservative management for postprostatectomy urinary incontinence. Cochrane Database System Rev. 2007;CD001843.
Goode PS, Burgio KL, Johnson 2nd TM, et al. Behavioral therapy with or without biofeedback and pelvic floor electrical stimulation for persistent postprostatectomy incontinence: a randomized controlled trial. JAMA. 2011;305:151–9.
Nabi G, Cody JD, Ellis G, et al. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2006;CD003781.
Helfand B, Evans RM, McVary KA. Comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients. Eur Urol. 2010;57:586–91.
Brubaker L, Fanning K, Goldberg E. Predictors of discontinuing overactive bladder medications. BJU Int. 2010;105(9):1283–90.
Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. A randomized controlled trial. JAMA. 2006;296:2319.
Tsakiris P, de la Rosette JJ, Michel MC, et al. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur Urol. 2008;53:53.
Filocamo MT, Li Marzi V, Del Popolo G, et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol. 2007;51:1559.
Schurch B, Reitz A. Botox in urology: a new treatment modality without limitations? EAU update series. 2004;2:170–8.
Flynn M, Amundsen C, Perevich M, et al. Outcome of a randomized double blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol. 2009;181:2608–15.
Khan S, Kessler T, Apostolidis A, et al. What a patient with refractory idiopathix detrusor overactivity should know about botulinum neurotoxiin type a injection. J Urol. 2009;181:1773–8.
Herbison GP, Arnold EP. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev. 2009;(2):CD004202.
Siddiqui N, Amundsen C, Visco A, et al. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence. J Urol. 2009;182:2799–804.
Herschorn S, Bruschini H, Comier C, et al. Surgical treatment of stress incontinence in men. Neurourol Urodyn. 2010;29:179.
Bauer RM, Bastian PJ, Gozzi C, et al. Postprostatectomy incontinence: all about diagnosis and management. Eur Urol. 2009;55:322.
Smith DN, Appell RA, Rackley RR, et al. Collagen injection therapy for post-prostatectomy incontinence. J Urol. 1998;160:364.
Westney OL, Bevan-Thomas R, Palmer JL, et al. Transurethral collagen injections for male intrinsic sphincter deficiency: the University of Texas-Houston experience. J Urol. 2005;174:994.
Comiter CV. The male sling for stress urinary incontinence: a prospective study. J Urol. 2002;167:597.
Gomes CM, Broderick GA, Sanchez-Ortiz RF, et al. Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol. 2000;163:87.
Kaufman JJ. A new operation for male incontinence. Surg Gynecol Obstet. 1970;131:295.
Schaeffer AJ, Clemens JQ, Ferrari M, et al. The male bulbourethral sling procedure for post-radical prostatectomy incontinence. J Urol. 1998;159:1510.
Stern JA, Clemens JQ, Tiplitsky S, et al. Long-term results of the bulbourethral sling procedure. J Urol. 2005;173:1654.
Comiter CV. Surgery insight: surgical management of postprostatectomy incontinence—the artificial urinary sphincter and male sling. Nat Clin Pract Urol. 2007;4:615.
Comiter CV. The male perineal sling: intermediate-term results. Neurourol Urodyn. 2005;24:648.
Onur R, Singla A. Comparison of bone-anchored male sling and collagen implant for the treatment of male incontinence. Int J Urol. 2006;13:1207.
Dikranian AH, Chang AH, Rhee JH, et al. The male perineal sling: comparison of sling materials. J Urol. 2004;172:608.
Rajpurkar AD, Onur R, Singla A. Patient satisfaction and clinical efficacy of the new perineal bone-anchored male sling. Eur Urol. 2005;47:237.
Castle EP, Andrews PE, Itano N, et al. The male sling for post-prostatectomy incontinence: mean followup of 18 months. J Urol. 2005;173:1657.
Flynn BJ, Webster GD. Evaluation and surgical management of intrinsic sphincter deficiency after radical prostatectomy. Rev Urol. 2004;6:180.
Fischer MC, Huckabay C, Nitti VW. The male perineal sling: assessment and prediction of outcomes. J Urol. 2007;177:1414.
Ullrich NF, Comiter CV. The male sling for stress urinary incontinence: urodynamic and subjective assessment. J Urol. 2004;172:204.
Clemens JQ, Bushman W, Schaeffer AJ. Urodynamic analysis of the bulbourethral sling procedure. J Urol. 1999;162:1977.
Suburethral synthetic sling insertion for stress urinary incontinence in men. National Institute for Health and Clinical Excellence. Available at http://guidance.nice.org.uk/IPG256. Accessed 12 July 2010.
Rehder P, Gozzi C. Transobturator sling suspension for male urinary incontinence including post-radical prostatectomy. Eur Urol. 2007;52:860.
Bauer RM, Mayer ME, Gratzke C, et al. Prospective evaluation of the functional sling suspension for male postprostatectomy stress urinary incontinence: results after 1 year. Eur Urol. 2009;56:928.
Davies TO, Bepple JL, McCammon KA. Urodynamic changes and initial results of the AdVance male sling. Urology. 2009;74:354.
Wilson SK, Delk JR, Henry GD, et al. New surgical technique for sphincter urinary control system using upper transverse scrotal incision. J Urol. 2003;169:261.
Kendrici M, Gupta S, Shaw K, et al. Synchronous prosthetic implantation through a transscrotal incision: an outcome analysis. J Urol. 2006;175:2218.
Henry GD, Graham SM, Cleves MA, et al. Perineal approach for artificial urinary sphincter implantation appears to control male stress incontinence better than the transscrotal approach. J Urol. 2008;179:1475.
O’Connor RC, Lyon MB, Guralnick MB, et al. Long-term follow-up of single versus double cuff artificial urinary sphincter insertion for the treatment of severe postprostatectomy stress urinary incontinence. Urology. 2008;71:90.
Guralnick ML, Miller E, Toh KL, et al. Transcorporal artificial urinary sphincter cuff placement in cases requiring revision for erosion and urethral atrophy. J Urol. 2002;167:2075.
Fleshner N, Herschorn S. The artificial urinary sphincter for post-radical prostatectomy incontinence: impact on urinary symptoms and quality of life. J Urol. 1996;155:1260.
Haab F, Trockman BA, Zimmern PE, et al. Quality of life and continence assessment of the artificial urinary sphincter in men with minimum 3.5 years of followup. J Urol. 1997;158:435.
Litwiller SE, Kim KB, Fone PD, et al. Post-prostatectomy incontinence and the artificial urinary sphincter: a long-term study of patient satisfaction and criteria for success. J Urol. 1996;156:1975.
Lai HH, Hsu EI, Teh BS, et al. 13 years of experience with artificial urinary sphincter implantation at Baylor College of Medicine. J Urol. 2007;177:1021.
Elliott DS, Barrett DM. Mayo Clinic long-term analysis of the functional durability of the AMS 800 artificial urinary sphincter: a review of 323 cases. J Urol. 1998;159:1206.
Clemens JQ, Schuster TG, Konnak JW, et al. Revision rate following artificial urinary sphincter placement for post-radical prostatectomy incontinence: actuarial analysis. J Urol. 2001;166:1372.
Venn SN, Greenwall TJ, Mundy AR. The long-term outcome of artificial urinary sphincters. J Urol. 2000;164:702.
Klijn AJ, Hop WCJ, Mickisch G, et al. The artificial urinary sphincter in men incontinent after radical prostatectomy: 5 years actuarial adequate function rates. BJU Int. 1998;82:530.
Fisher MB, Aggarwal N, Vuruskan H, et al. Efficacy of artificial urinary sphincter implantation after failed bone-anchored male sling for postprostatectomy incontinence. Urology. 2007;70:942.
Kumar A, Litt ER, Ballert KN, et al. Artificial urinary sphincter versus male sling for post-prostatectomy incontinence – what do patients choose? J Urol. 2009;181:1231.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Atiemo, H., Clemens, J.Q. (2012). Managing Overactive Bladder and Urinary Incontinence in the Male. In: Shoskes, D. (eds) Urological Men’s Health. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-900-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-61779-900-6_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-899-3
Online ISBN: 978-1-61779-900-6
eBook Packages: MedicineMedicine (R0)